The first clinical trial in patients with monkeypox of an antiviral drug that could speed their recovery has begun in the UK.
The trial, known as Platinum, will explore whether Tecovirimat – a drug originally developed for smallpox – may reduce the length of time it takes for skin lesions and ulcers to heal.